EP
ROIV icon

Edgestream Partners’s Roivant Sciences ROIV Stock Holding History

Edgestream Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93M Buy
82,811
+42,004
+103% +$1.24M 0.09% 417
2026
Q1 		$1.13M Buy
+40,807
New +$1.05M 0.04% 610
2024
Q4 		– Sell
-48,226
Closed -$557K – 1048
2024
Q3 		$557K Buy
+48,226
New +$549K 0.02% 680
2024
Q1 		– Sell
-35,815
Closed -$402K – 990
2023
Q4 		$402K Buy
+35,815
New +$349K 0.03% 657

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Edgestream Partners's ROIV Position: Q2 2026 in Review

Edgestream Partners increased its Roivant Sciences (ROIV) stake by 103% in Q2 2026, buying an estimated $1.24M and bringing the position to 82,811 shares worth $2.93M. The position accounts for 0.09% of the portfolio, ranked #417.

Edgestream Partners first reported a position in ROIV in Q4 2023 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Edgestream Partners held 82,811 shares of Roivant Sciences worth $2.93M as of Q2 2026.
  • Edgestream Partners bought 42,004 Roivant Sciences shares in Q2 2026, an estimated $1.24M.
  • Roivant Sciences made up 0.09% of Edgestream Partners's portfolio in Q2 2026, its #417 holding.
  • Edgestream Partners first reported a position in Roivant Sciences in Q4 2023 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.